BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 4080957)

  • 1. Nephrotic range proteinuria--a good predictive index of disease in IgA nephropathy?
    Lai KN; Ho CP; Chan KW; Yan KW; Lai FM; Vallance-Owen J
    Q J Med; 1985 Oct; 57(222):677-88. PubMed ID: 4080957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial.
    Lai KN; Lai FM; Ho CP; Chan KW
    Clin Nephrol; 1986 Oct; 26(4):174-80. PubMed ID: 3536231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
    Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can immunosuppressive drugs slow the progression of IgA nephropathy?
    Goumenos D; Ahuja M; Shortland JR; Brown CB
    Nephrol Dial Transplant; 1995; 10(7):1173-81. PubMed ID: 7478120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
    Uzu T; Harada T; Ko M; Yamato M; Takahara K; Yamauchi A
    Clin Exp Nephrol; 2003 Sep; 7(3):210-4. PubMed ID: 14586717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors for progression in immunoglobulin A nephropathy with significant proteinuria.
    Hwang HS; Kim BS; Shin YS; Yoon HE; Song JC; Choi BS; Park CW; Yang CW; Kim YS; Bang BK
    Nephrology (Carlton); 2010 Mar; 15(2):236-41. PubMed ID: 20470285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgA nephropathy in patients over 50 years of age: a multicentre, prospective study.
    Frimat L; Hestin D; Aymard B; Mayeux D; Renoult E; Kessler M
    Nephrol Dial Transplant; 1996 Jun; 11(6):1043-7. PubMed ID: 8671966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Steroid-responsive nephrotic syndrome in IgA nephropathy].
    García Camín RM; Cabezas A; Calero F; Ballarín JA
    Nefrologia; 2004; 24 Suppl 3():68-71. PubMed ID: 15219073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
    Trimarchi H; Muryan A; Young P; Forrester M; Iotti A; Pereyra H; Lombi F; Seminario O; Alonso M; Iotti R
    Medicina (B Aires); 2007; 67(5):445-50. PubMed ID: 18051227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors predicting progression of IgA nephropathies.
    Coppo R; D'Amico G
    J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applicability of steroid therapy in 275 adult patients with IgA nephropathy determined using a histological scoring system and degree of proteinuria.
    Suzuki S; Joh K
    Clin Exp Nephrol; 2004 Jun; 8(2):109-16. PubMed ID: 15235927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macroscopic hematuria in childhood IgA nephropathy.
    Yoshikawa N; Ito H; Iijima K; Nakahara C; Maehara K; Hasegawa O; Okada S; Matsuo T
    Clin Nephrol; 1987 Nov; 28(5):217-21. PubMed ID: 3427831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological alterations in renal specimens as indicators of prognosis of IgA nephropathy.
    Okada H; Suzuki H; Konishi K; Sakaguchi H; Saruta T
    Clin Nephrol; 1992 May; 37(5):235-8. PubMed ID: 1606773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature.
    Ibels LS; Györy AZ
    Medicine (Baltimore); 1994 Mar; 73(2):79-102. PubMed ID: 8152367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
    Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
    Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berger's disease in children. Natural history and outcome.
    Lévy M; Gonzalez-Burchard G; Broyer M; Dommergues JP; Foulard M; Sorez JP; Habib R
    Medicine (Baltimore); 1985 May; 64(3):157-80. PubMed ID: 3887094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of pathologic findings in individuals with nephrotic proteinuria according to serum albumin.
    Gupta K; Iskandar SS; Daeihagh P; Ratliff HL; Bleyer AJ
    Nephrol Dial Transplant; 2008 May; 23(5):1595-9. PubMed ID: 18065791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.